|
|
- |
uncharacterized LOC254896 |
|
|
|
|
|
- |
putative uncharacterized protein MGC39545 |
|
|
|
|
|
- |
TCR gamma alternate reading frame protein |
|
|
|
|
|
A2M |
alpha-2-macroglobulin |
- Platelet degranulation
- Intrinsic Pathway of Fibrin Clot Formation
- Degradation of the extracellular matrix
- HDL assembly
|
- Becaplermin
- Cisplatin
- Bacitracin
- Zinc
- Ocriplasmin
- Silver
- Zinc acetate
- Zinc chloride
- Zinc sulfate, unspecified form
|
|
|
|
AAK1 |
AP2 associated kinase 1 |
- Cargo recognition for clathrin-mediated endocytosis
- Clathrin-mediated endocytosis
|
|
|
|
|
AAMDC |
adipogenesis associated Mth938 domain containing |
|
|
|
|
|
ABCB7 |
ATP binding cassette subfamily B member 7 |
- Mitochondrial ABC transporters
- Cytosolic iron-sulfur cluster assembly
|
|
- Sideroblastic anemia, including: Pyridoxine-refractory autosomal recessive sideroblastic anemia (PRARSA); X-linked sideroblastic anemia (XLSA); X-linked sideroblastic anemia with ataxia (ASAT)
|
|
|
ABCF1 |
ATP binding cassette subfamily F member 1 |
- ABC-family proteins mediated transport
|
|
|
|
|
ABHD10 |
abhydrolase domain containing 10, depalmitoylase |
|
|
|
|
|
ABHD11 |
abhydrolase domain containing 11 |
|
|
|
|
|
ABL1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
- Regulation of actin dynamics for phagocytic cup formation
- Role of ABL in ROBO-SLIT signaling
- Role of ABL in ROBO-SLIT signaling
- Myogenesis
- Myogenesis
- RHO GTPases Activate WASPs and WAVEs
- HDR through Single Strand Annealing (SSA)
- Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
- Cyclin D associated events in G1
- RUNX1 regulates transcription of genes involved in differentiation of HSCs
- RUNX2 regulates osteoblast differentiation
- FCGR3A-mediated phagocytosis
- Factors involved in megakaryocyte development and platelet production
- MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
- Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
|
- ATP
- Imatinib
- Dasatinib
- N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide
- Nilotinib
- XL228
- Bosutinib
- 2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE
- 1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA
- Myristic acid
- PD-166326
- 5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE
- 2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide
- Regorafenib
- Ponatinib
- Fostamatinib
- Brigatinib
- Radotinib
- Asciminib
- Umbralisib
|
- Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia)
- Chronic myeloid leukemia (CML)
|
|
|
ABLIM1 |
actin binding LIM protein 1 |
- DCC mediated attractive signaling
|
|
|
|
|
ABR |
ABR activator of RhoGEF and GTPase |
- NRAGE signals death through JNK
- G alpha (12/13) signalling events
- RHOA GTPase cycle
- RHOB GTPase cycle
- RHOC GTPase cycle
- CDC42 GTPase cycle
- RAC1 GTPase cycle
- RAC2 GTPase cycle
- RAC3 GTPase cycle
|
|
|
|
|
ABT1 |
activator of basal transcription 1 |
|
|
|
|
|
ACAA2 |
acetyl-CoA acyltransferase 2 |
- Mitochondrial Fatty Acid Beta-Oxidation
|
|
|
|
|
ACAD10 |
acyl-CoA dehydrogenase family member 10 |
- Mitochondrial Fatty Acid Beta-Oxidation
|
|
|
|
|
ACAD11 |
acyl-CoA dehydrogenase family member 11 |
- Mitochondrial Fatty Acid Beta-Oxidation
|
|
|
|
|
ACBD4 |
acyl-CoA binding domain containing 4 |
- Peroxisomal lipid metabolism
|
|
|
|
|
ACBD6 |
acyl-CoA binding domain containing 6 |
- Mitochondrial Fatty Acid Beta-Oxidation
|
|
|
|
|
ACHE |
acetylcholinesterase (Yt blood group) |
- Neurotransmitter clearance
- Synthesis of PC
- Synthesis, secretion, and deacylation of Ghrelin
|
- Choline
- Tacrine
- Dipivefrin
- Gallamine triethiodide
- Pyridostigmine
- Galantamine
- Isoflurophate
- Pralidoxime
- Minaprine
- Donepezil
- Ranitidine
- Ethanol
- Demecarium
- Physostigmine
- Rivastigmine
- Edrophonium
- Ambenonium
- Tubocurarine
- Decamethonium
- Neostigmine
- Monoisopropylphosphorylserine
- Propidium
- 3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium
- 3,6,9,12,15-Pentaoxaheptadecane
- 1-Deoxy-1-Thio-Heptaethylene Glycol
- (4aS,6R,8aS)-11-[8-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)octyl]-6-hydroxy-3-methoxy-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium
- Methylphosphinate
- Methylphosphinic Acid
- 3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium
- beta-L-fucose
- Huperzine B
- M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene
- N-acetyl-alpha-D-glucosamine
- 2-(N-morpholino)ethanesulfonic acid
- MF268
- 3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine
- NAP-226-90
- (R)-tacrine(10)-hupyridone
- (S)-tacrine(10)-hupyridone
- TACRINE(8)-4-AMINOQUINOLINE
- (9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM
- Zanapezil
- Huperzine A
- Phenserine
- Itopride
- Ganstigmine
- Hydroxy(oxo)(2-{(1S)-2,2,2-trifluoro-1-[2-(trimethylarsonio)ethoxy]ethyl}phenyl)ammonium
- 1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE
- 1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL
- (3,4,8b-Trimethyl-3-oxido-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-3-ium-7-yl) N-(2-ethylphenyl)carbamate
- Methylthioninium
- Diethylene glycol diethyl ether
- 2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM
- Dimetacrine
- Terpinen-4-ol
- Tyrothricin
- Choline salicylate
|
|